134 related articles for article (PubMed ID: 2220756)
21. [Histological diagnosis of Ph-negative myeloproliferative neoplasia. An overview].
Campr V
Cesk Patol; 2011 Jul; 47(3):84-93. PubMed ID: 21887923
[TBL] [Abstract][Full Text] [Related]
22. Identification of mRNA for PDGF B-chain in human megakaryocytes isolated using a novel immunomagnetic separation method.
Gladwin AM; Carrier MJ; Beesley JE; Lelchuk R; Hancock V; Martin JF
Br J Haematol; 1990 Nov; 76(3):333-9. PubMed ID: 2261343
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of c-sis mRNA expression by human megakaryocytic cells in normals and patients with myeloproliferative disorders.
Kanz L; Mielke R; Fauser AA; Löhr GW
Adv Exp Med Biol; 1988; 241():73-80. PubMed ID: 3066169
[No Abstract] [Full Text] [Related]
24. [Role of PDGF on myeloproliferative disorders].
Kimura A; Katoh O; Kuramoto A
Rinsho Ketsueki; 1988 Jul; 29(7):989-93. PubMed ID: 3184485
[No Abstract] [Full Text] [Related]
25. Thrombopoietin receptor (Mpl) expression by megakaryocytes in myeloproliferative disorders.
Bock O; Schlué J; Mengel M; Büsche G; Serinsöz E; Kreipe H
J Pathol; 2004 May; 203(1):609-15. PubMed ID: 15095485
[TBL] [Abstract][Full Text] [Related]
26. Relation of platelet abnormalities to thrombosis and hemorrhage in chronic myeloproliferative disorders.
Wehmeier A; Südhoff T; Meierkord F
Semin Thromb Hemost; 1997; 23(4):391-402. PubMed ID: 9263357
[TBL] [Abstract][Full Text] [Related]
27. [Emperipolesis in megakaryocytes in patients with thrombocytosis in the course of myeloproliferative disorders].
Bobik R; Podolak-Dawidziak M; Kiełbiński M; Jeleń M; Wróbel T
Acta Haematol Pol; 1995; 26(2):179-83. PubMed ID: 7653223
[TBL] [Abstract][Full Text] [Related]
28. Transforming growth factor-beta regulates growth as well as collagen and fibronectin synthesis of human marrow fibroblasts.
Kimura A; Katoh O; Hyodo H; Kuramoto A
Br J Haematol; 1989 Aug; 72(4):486-91. PubMed ID: 2789074
[TBL] [Abstract][Full Text] [Related]
29. Circulating megakaryocyte progenitors in myeloproliferative disorders are hypersensitive to interleukin-3.
Kobayashi S; Teramura M; Hoshino S; Motoji T; Oshimi K; Mizoguchi H
Br J Haematol; 1993 Apr; 83(4):539-44. PubMed ID: 7686030
[TBL] [Abstract][Full Text] [Related]
30. Current diagnostic criteria for the chronic myeloproliferative disorders (MPD) essential thrombocythemia (ET), polycythemia vera (PV) and chronic idiopathic myelofibrosis (CIMF).
Michiels JJ; Bernema Z; Van Bockstaele D; De Raeve H; Schroyens W
Pathol Biol (Paris); 2007 Mar; 55(2):92-104. PubMed ID: 16919893
[TBL] [Abstract][Full Text] [Related]
31. Beta-thromboglobulin content in megakaryocytes of patients with myeloproliferative diseases.
Grossi A; Vannucchi AM; Rafanelli D; Filimberti E; Rossi Ferrini P
Thromb Res; 1986 Aug; 43(3):367-74. PubMed ID: 2426823
[No Abstract] [Full Text] [Related]
32. Changes in the mitogenic activity of platelet-derived growth factor(s) in patients with myeloproliferative disease.
Caenazzo A; Pietrogrande F; Polato G; Piva E; Masiero M; Sgarabotto D; Girolami A
Acta Haematol; 1989; 81(3):131-5. PubMed ID: 2496560
[TBL] [Abstract][Full Text] [Related]
33. Platelet-derived mitogenic activity and bone marrow fibrosis in myeloproliferative disorders.
Romano M; Viero P; Cortellazzo S; Barbui T; Donati MB; Poggi A
Haemostasis; 1990; 20(3):162-8. PubMed ID: 2143744
[TBL] [Abstract][Full Text] [Related]
34. Abnormal levels of platelet-specific proteins and mitogenic activity in myeloproliferative disease.
Rueda F; Piñol G; Marti F; Pujol-Moix N
Acta Haematol; 1991; 85(1):12-5. PubMed ID: 1826402
[TBL] [Abstract][Full Text] [Related]
35. Regulation of platelet-derived growth factor A and B chain gene expression in bone marrow stromal cells.
Abboud SL
J Cell Physiol; 1995 Aug; 164(2):434-40. PubMed ID: 7622589
[TBL] [Abstract][Full Text] [Related]
36. Clinicopathological diagnosis and differential criteria of thrombocythemias in various myeloproliferative disorders by histopathology, histochemistry and immunostaining from bone marrow biopsies.
Thiele J; Kvasnicka HM; Diehl V; Fischer R; Michiels J
Leuk Lymphoma; 1999 Apr; 33(3-4):207-18. PubMed ID: 10221501
[TBL] [Abstract][Full Text] [Related]
37. Increased Dkk3 protein expression in platelets and megakaryocytes of patients with myeloproliferative neoplasms.
Medinger M; Tzankov A; Kern J; Pircher A; Hermann M; Ott HW; Gastl G; Untergasser G; Gunsilius E
Thromb Haemost; 2011 Jan; 105(1):72-80. PubMed ID: 20978717
[TBL] [Abstract][Full Text] [Related]
38. Histologic findings in bone marrow biopsies of patients with thrombocythemic cell counts.
Buhr T; Georgii A; Schuppan O; Amor A; Kaloutsi V
Ann Hematol; 1992 Jun; 64(6):286-91. PubMed ID: 1637884
[TBL] [Abstract][Full Text] [Related]
39. Increased circulating CSF-1 (M-CSF) in myeloproliferative disease: association with myeloid metaplasia and peripheral bone marrow extension.
Gilbert HS; Praloran V; Stanley ER
Blood; 1989 Sep; 74(4):1231-4. PubMed ID: 2669997
[TBL] [Abstract][Full Text] [Related]
40. Human melanoma cell lines of primary and metastatic origin express the genes encoding the chains of platelet-derived growth factor (PDGF) and produce a PDGF-like growth factor.
Westermark B; Johnsson A; Paulsson Y; Betsholtz C; Heldin CH; Herlyn M; Rodeck U; Koprowski H
Proc Natl Acad Sci U S A; 1986 Oct; 83(19):7197-200. PubMed ID: 3020539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
